Clinical Trial Update: A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Results from a Phase 1/2 study of MM-121 in combination therapy for advanced non-small cell lung cancer have been posted. The trial, sponsored by Merrimack Phar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• MM-121 (seribantumab)

Snippet

Sponsor: Merrimack Pharmaceuticals | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-08-22